Status:
RECRUITING
Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China
Lead Sponsor:
Beijing Tiantan Hospital
Collaborating Sponsors:
Beijing Chao Yang Hospital
Peking University International Hospital
Conditions:
Dissecting Aneurysm of Cerebral Artery
Eligibility:
All Genders
18-80 years
Brief Summary
The incidence of vertebrobasilar dissecting aneurysms (VBDAs) is about 1/100,000\~1.5/100,000, and it is one of the most important causes of stroke in young and middle-aged people. In recent years, wi...
Eligibility Criteria
Inclusion
- Age 18-80 years old;
- Patients diagnosis of "unruptured vertebrobasilar dissecting aneurysm".
Exclusion
- Patients did not undergo a cranial MRI;
- Missing critical clinical baseline;
- Missing pre-treatment imaging;
- Receiving microsurgery;
- The combination of other serious diseases during diagnosis will significantly affect the follow-up of patients;
- CT/MRI shows intracranial hemorrhage or subarachnoid hemorrhage (SWI microbleeds are ignored).
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2032
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06541106
Start Date
January 1 2011
End Date
January 1 2032
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100010